Enantiomeric resolution of a novel chiral cannabinoid receptor ligand

Journal of Biochemical and Biophysical Methods

Volumn 54, Issue 1-3, 2002, Pages 415-422

  Thakur, Ganesh A ^a   Palmer, Sonya L ^a   Harrington, Paul E ^b   Stergiades, Ioanna A ^b   Tius, Marcus A ^b   Makriyannis, Alexandros ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

9 THC; Cannabinoid receptors; ChiralPak AD column; Hybrid cannabinoids

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; LIGAND;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CHIRALITY; COLUMN CHROMATOGRAPHY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG BINDING; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOSE; ANIMALS; CANNABINOIDS; CARBAMATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; KIDNEY; LIGANDS; MEMBRANES; MICE; PHENYLCARBAMATES; PROSENCEPHALON; PROTEIN BINDING; RATS; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SPLEEN; STEREOISOMERISM; SYNAPTOSOMES;

EID: 0037207256     PISSN: 0165022X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-022X(02)00144-6     Document Type: Article

References (26)

1. (a) Mechoulam R. Cannabinoids as therapeutic agents. Boca Raton (FL): CRC Press; 1986;
2. (b) Nye JS, Snowman AM, Voglmaier S, Snyder SH. High-affinity cannabinoid binding site: regulation by ions, ascorbic acid, and nucleotides. J Neurochem 1989;52:1892;
3. (c) Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Neurochem 1988;247:1046;
4. (d) Feigenbaum JJ, Richmond SA, Weissman Y, Mechoulam R. Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid. J Neurochem 1989;169:159;
5. (e) Howlett AC, Johnson MR, Melvin LS, Milne GM. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. J Neurochem 1988;33:297;
6. (f) Khanolkar AD, Palmer SL, Makriyannis A. Molecular probes for the cannabinoid receptors. J Neurochem 2000;108:37.
7. (a) Devane WA, Dysarz III FA, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of cannabinoid receptor in rat brain. Mol Pharmacol 1988;34:605;
8. (b) Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Mol Pharmacol 1990;346:561.
9. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61.
10. Kaminski N.E., Abood M.E., Kessler F.K., Martin B.R., Schatz A.R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharmacol. 42:1992;736.
11. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G.et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946.
12. (a) Makriyannis A., Rapaka R.S. The molecular basis of cannabinoid activity. Life Sci. 47:1990;2173;
13. (b) Razdan R.K. Structure-activity relationships in cannabinoids. Pharmacol. Rev. 38:1986;75.
14. Johnson M.R., Melvin L.S. Mechoulam R. In cannabinoids as therapeutic agents. 1986;121 CRC Press, Boca Raton, FL.
15. Wilson R.S., May E.L. Analgesic properties of the tetrahydrocannabinols, their metabolites and analogues. J. Med. Chem. 18:1975;700.
16. Tius M.A., Makriyannis A., Zou X.L., Abadji V. Conformationally restricted hybrids of CP-55,940 and HHC: stereoselective synthesis and activity. Tetrahedron. 50:1994;2671.
17. (a) Tius M.A., Hill W.A.G., Zou X.L., Busch-Petersen J., Kawakami J.K., Fernandez-Garcia M.C.et al. Classical/non-classical cannabinoid hybrids; stereochemical requirements for the southern hydroxyalkyl chain. Life Sci. 56:1995;2007;
18. (b) Drake D.J., Jensen R.S., Busch-Petersen J., Kawakami J.K., Fernandez-Garcia M.C., Fan P.et al. Classical/nonclassical hybrid cannabinoids: southern aliphatic chain-functionalized C-6β methyl, ethyl, and propyl analogues. J. Med. Chem. 41:1998;3596.
19. Harrington P.E., Stergiades I.A., Erickson J., Makriyannis A., Tius M.A. Synthesis of functionalized cannabinoids. J. Org. Chem. 65:2000;6576.
20. Dodd P.R., Hardy J.A., Oakley A.E., Edwardson J.A., Perry E.K., Delaunoy J.-P. A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res. 226:1981;107.
21. 50) of any enzymatic reaction. Biochem. Pharmacol. 22:1973;3099.
22. Yin D., Khanolkar A.D., Makriyannis A., Froimowitz M. Chiral resolution of 1,3-dimethyl-4-phenylpiperidine derivatives using high-performance liquid chromatography with a chiral stationary phase. J. Chromatogr., A. 678:1994;176.
23. Lin S., Duclos R.I., Makriyannis A. Preparation of optically pure 4-(hydroxymethyl)-2-pentadecyl-1,3-dioxananes and their corresponding phosphodiester ether lipid derivatives. Chem. Phys. Lipids. 113:2001;111.
24. (a) Shulamit L., Abu-Lafi S., Zahalka J., Mechoulam R. Resolution of chiral cannabinoids on amylose tris(3,5-dimethylphenylcarbmate) chiral stationary phase: effects of structural features and mobile phase additives. J. Chromatogr., A. 654:1993;53;
25. (b) Levin S., Sterin M., Abu-Lafi S. Structural features affecting chiral resolution of cannabimimetic enantiomers by amylose 3,5-dimethylphenylcarbamate chiral stationary phase. Chirality. 7:1995;140.
26. 8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain. J. Med. Chem. 37:1994;3867.